Cellon debuts sterile single-use containers
The range is ideal for use in the handling and storage of biologicals
Called PharmaTainer, the line of products are a range of low particulate, single use bottles and carboys for the storage/transport of bulk vaccines, biopharmaceuticals, culture media and other biotech materials.
The plastic containers are injection blow moulded in an ISO Class 5 (Class100) environment and radiation sterilised. These rigid ultra-clean containers are available in sizes from 125ml to 20L. They are manufactured from resins approved for medical applications in PET or polycarbonate with HDPE closures.
PharmaTainer packaging features three inner layers of poly wrapping to facilitate delivery into cleanroom areas. The inner most layer is vacuum-sealed providing tamper evidence and assurance of an intact sterility barrier.
The range of products feature traceability down to the individual container. Each bottle/carboy is printed with a unique serial number, batch number, expiration date and a machine-readable data matrix. The machine-readable serial number can be readily integrated with the user’s inventory management system.
All PharmaTainer products are produced in a new, moulding facility, dedicated solely to production of sterile, single-use products for biotechnology industries.
European customers may get further information at www.cellon.lu or by email sales@cellon.lu. The products are distributed by Biofluid Focus in North American (www.biofluidfocus.com).
You may also like
Trending Articles
You may also like
Pharmaceutical
CPHI Frankfurt 2025 to welcome more than 60,000 pharma professionals with expanded focus on innovation and sustainability
Returning to Germany from 28-30 October, CPHI Frankfurt 2025 will unite the global pharmaceutical supply chain with more than 2000 exhibitors, six content theatres and new feature zones
Manufacturing
Continuous innovation: redefining the future of pharmaceutical manufacturing
In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced